by Kharrazian Institute | Aug 14, 2026 | Blog, Mood and Anxiety
Most practitioners treating depression are still asking one question: which neurotransmitter is deficient? Research in neuroimmunology has been asking a different one for years: which inflammatory pathway is active? The clinical gap between those two questions is...
by Kharrazian Institute | Aug 13, 2026 | Blog, Cognitive Decline and Dementia
Most practitioners ordering a cognitive workup are asking one question: is this Alzheimer’s or isn’t it? That’s the wrong question. Cognitive decline has a differential diagnosis as broad and mechanistically distinct as any other complex chronic...
by Kharrazian Institute | Aug 12, 2026 | Blog, Cognitive Decline and Dementia
A practitioner’s most common mistake with dementia patients is treating the brain last. The gut gets addressed, the liver gets supported, the hormones get balanced — and the organ driving the patient’s decline receives the least direct clinical attention....
by Kharrazian Institute | Aug 11, 2026 | Blog, Childhood Development
Most practitioners understand that early childhood matters for brain development. Fewer appreciate how precisely timed that window is — or how many distinct biological systems must converge correctly within it. The Kharrazian Institute’s pediatric...
by Kharrazian Institute | Aug 10, 2026 | Blog, Childhood Development
Most developmental disorder evaluations begin at birth or after. The neuroimmunology research suggests they should begin before conception. Maternal immune function during pregnancy is now recognized as one of the most significant determinants of fetal brain...
